Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

1. At a Glance

• Central Sector Scheme of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, providing quality generic medicines at 50–80% lower MRP than branded equivalents through Jan Aushadhi Kendras (JAKs) [1][2].
• Implementing agency: Pharmaceuticals & Medical Devices Bureau of India (PMBI) — earlier called Bureau of Pharma PSUs of India (BPPI) [3][4].
• Flagship of India's push to cut out-of-pocket health expenditure (~70% of household health spend is on medicines); relevant for GS-II (health, governance) and GS-III (pharma sector) [1].

2. Why in the News

• Janaushadhi Saptah 2026 (1–7 March 2026) and the 8th Janaushadhi Diwas on 7 March 2026 — nationwide health camps and outreach [1][2].
• PIB Backgrounder (7 Mar 2026) reaffirming the target of 25,000 Kendras by March 2027, with 18,000+ JAKs already operational [1].
• Crossing of 100 crore Suvidha sanitary pads sold by 31 January 2026 [3].

3. Background & Evolution

• Launched in 2008 as "Jan Aushadhi Campaign" by Department of Pharmaceuticals; re-launched and rebranded as PMBJP in November 2015 with expanded scope [1].
• Implementing body BPPI established in December 2008 under DoP; later renamed PMBI [3][4].
• 2019: launched Jan Aushadhi Suvidha Oxo-biodegradable Sanitary Napkin at ₹1/pad and Jan Aushadhi Sugam mobile app [3].
• Nov 2023: PM inaugurated the 10,000th Kendra at AIIMS Deoghar (Jharkhand) and announced expansion to 25,000 Kendras [5].
• FY 2023-24: crossed ₹1,000 crore in annual sales [6].

4. Core Static Facts

• Parent Ministry: Ministry of Chemicals & Fertilizers → Department of Pharmaceuticals [1].
• Implementing Agency: PMBI (Pharmaceuticals & Medical Devices Bureau of India) — a society under DoP [3].
• Scheme type: Central Sector Scheme (100% Union-funded) [1].
• Product basket: 1,965 medicines + 293 surgical/consumable items across all major therapeutic groups (anti-infectives, anti-diabetics, cardiovascular, anti-cancer, GI) [3].
• Current network: 18,646 JAKs (as of 28 Feb 2026) [2]; target 25,000 by March 2027 [1][2].
• Footfall: ~10–12 lakh visitors per day [2].
• Cumulative sales: ~₹7,700 crore MRP value by June 2025; estimated citizen savings ~₹38,000 crore vs branded equivalents [2].
• Incentive to Kendra owners: up to ₹5 lakh general; special incentive up to ₹2 lakh for Women, SC/ST, Divyangjan, ex-servicemen, and Kendras in aspirational districts / NE / Himalayan / island regions [1].
• Quality: medicines procured from WHO-GMP certified suppliers; tested at NABL-accredited labs [1].
• Flagship products: Suvidha sanitary napkin at ₹1/pad (>100 crore pads sold by Jan 2026) [1][3].
• Digital interface: Jan Aushadhi Sugam app (launched 2019) — locate Kendras, check medicine price & stock [3].

5. Multi-Dimensional Analysis

Economic / Health-financing

• Cuts out-of-pocket expenditure (OOPE) — a key NHP-2017 goal of reducing OOPE to 25% of total health spend [1].
• ~₹38,000 crore in cumulative consumer savings estimated by mid-2025 [2].

Social / Equity

• Franchisee model democratises pharma retail; reserved incentive of ₹2 lakh for women, SC/ST, Divyangjan and veterans promotes inclusive entrepreneurship [1].
• ₹1 Suvidha napkin advances menstrual hygiene for low-income women; addresses period-poverty [1][3].
• Rural penetration through franchisee model addresses medicine deserts in remote areas [1][2].

Administrative / Governance

• PMBI centrally procures and supplies via regional warehouses (e.g., Chennai, Gurugram, Guwahati, Surat) reducing logistics gaps [4].
• Online application portal janaushadhi.gov.in for transparent allotment of Kendras [2].

Scientific / Quality Assurance

• All drugs WHO-GMP compliant; batch-wise testing at NABL labs — counters the prejudice that "generics = inferior" [1].

Ethical

• Aligns with Article 47 (DPSP) — State's duty to raise nutrition and public health; advances SDG-3 (Good Health) and SDG-3.8 (UHC, access to affordable essential medicines) [1].

6. Recent Developments (last 12-18 months)

• 7 Mar 2026: PIB Backgrounder reiterating 25,000-Kendra target by March 2027 [1].
• 1–7 Mar 2026: Janaushadhi Saptah 2026 with health camps across states incl. Assam, Andhra Pradesh [2][7].
• 31 Jan 2026: cumulative Suvidha napkin sales cross 100 crore units [3].
• June 2025: cumulative sales ~₹7,700 crore (MRP); savings to citizens ~₹38,000 crore [2].
• FY 2023-24: ₹1,000 crore annual sales target achieved [6].
• Nov 2023: 10,000th Kendra at AIIMS Deoghar; expansion roadmap to 25,000 announced by PM [5].

7. Prelims Hooks

• PMBJP launched in 2008; re-launched in November 2015 [1].
• Implementing agency: PMBI (formerly BPPI, est. December 2008) [3][4].
• Parent ministry: Ministry of Chemicals & Fertilizers — Department of Pharmaceuticals (NOT Ministry of Health) [1].
• Generic medicines priced 50–80% below branded MRP [1][2].
• Product basket: 1,965 medicines + 293 surgical items [3].
• Suvidha sanitary napkin introduced in 2019, priced at ₹1/pad, oxo-biodegradable [3].
• Jan Aushadhi Sugam app launched in 2019 [3].
• 18,000+ JAKs operational; target 25,000 by March 2027 [1][2].
• Janaushadhi Diwas observed on 7 March annually (8th edition in 2026) [1].
• 10,000th Kendra inaugurated by PM at AIIMS Deoghar (Jharkhand) in Nov 2023 [5].
• Special incentive of ₹2 lakh for Women, SC/ST, Divyangjan, ex-servicemen [1].
• Medicines sourced from WHO-GMP certified manufacturers; tested at NABL labs [1].
• Cumulative savings estimated at ~₹38,000 crore to citizens (by June 2025) [2].

8. Mains Relevance

• GS-II: Issues relating to development & management of Social Sector — Health; Welfare schemes for vulnerable sections.
• GS-III: Indian economy — issues of pharmaceutical sector, indigenous manufacturing, MSMEs.
• Question stems: 1. "Generic medicines alone cannot reduce out-of-pocket health expenditure unless prescription practices change." Critically examine in the context of PMBJP. (GS-II) 2. Evaluate PMBJP as an instrument of inclusive entrepreneurship and last-mile health access, citing its incentive structure and Suvidha sub-scheme. (GS-II) 3. Discuss the role of PMBI and the franchisee model in operationalising the National Health Policy 2017 goal of universal access to essential medicines. (GS-II)

9. Related Topics to Study Next

• National Health Policy 2017 — sets OOPE-reduction target PMBJP serves.
• Ayushman Bharat (PM-JAY & HWCs) — complementary affordable-care pillar.
• DPCO 2013 & NPPA — price-control regime for essential medicines.
• National List of Essential Medicines (NLEM 2022) — overlap with Jan Aushadhi basket.
• Production Linked Incentive (PLI) for Pharma & Bulk Drugs — supply-side complement.
• Pradhan Mantri Bhartiya Janaushadhi Kendra (PMBJK) franchisee guidelines — operational layer.
• SDG-3 (UHC) and Article 47 DPSP — normative anchor.
• Suvidha napkin & Menstrual Hygiene Scheme (MoHFW) — gender-health convergence.

10. Common Errors / Trap Areas

• Wrong ministry: PMBJP is under DoP / Min. of Chemicals & Fertilizers, NOT Ministry of Health & Family Welfare [1].
• BPPI vs PMBI: agency was renamed — current name is PMBI [3].
• Launch year confusion: scheme originated in 2008; re-launched/rebranded as PMBJP in 2015 — both dates examinable [1].
• Suvidha napkin price: ₹1 per pad (often misquoted as ₹2.50, the original 2018 price) [1][3].
• Janaushadhi Diwas date: 7 March (not 1 March or 8 March) [1].
• PMBJP supplies generic medicines, not "free" medicines — they are sold, only cheaper.